In this episode of TECHNE Connect to Visionaries, Karim is joined by Shreyas, COO and Co-Founder of Katalyse AI, to explore the role of artificial intelligence in transforming pharmaceutical development and improving access to life-saving medicines.
Shreyas shares his journey from competitive tennis to entrepreneurship, including his experience at BCG and Sanofi, where he gained insight into the challenges facing the pharmaceutical industry. Witnessing inequalities in access to essential medicines inspired his ambition to help develop technology addressing these challenges.
We explore how Katalyse AI is helping pharmaceutical companies accelerate drug development, improve processes and reduce manufacturing costs through AI-driven solutions.
The conversation also covers the realities of building a startup, securing early customers, developing a mission-driven company culture and attracting talented people who share the organisation's ambitions.
Looking ahead, Shreyas discusses the future of AI in healthcare, why curiosity and problem-solving are becoming increasingly important skills, and his advice for the next generation of engineers and entrepreneurs considering a career in health tech.
A conversation about entrepreneurship, leadership and the potential of AI to make healthcare more accessible worldwide.
","author_name":"Techne Studios"}